Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CORT Corcept Therapeutics	$71.88 -1.8%	$65.28	$22.60 ▼ $117.33	$7.58B	0.15	1.13 million shs	810,038 shs
JAZZ Jazz Pharmaceuticals	$116.96 +0.5%	$123.41	$95.49 ▼ $148.06	$7.10B	0.42	801,788 shs	1.13 million shs
MDCO Medicines	$84.90	$84.90	$17.81 ▼ $84.98	$6.77B	1.1	9.55 million shs	N/A
RPRX Royalty Pharma	$32.82 +0.3%	$32.50	$24.05 ▼ $34.20	$18.92B	0.5	3.26 million shs	4.55 million shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CORT Corcept Therapeutics	+3.21%	+13.22%	+34.05%	+19.02%	+213.35%
JAZZ Jazz Pharmaceuticals	+3.12%	+12.60%	-5.30%	-6.32%	+4.67%
MDCO Medicines	0.00%	0.00%	0.00%	0.00%	0.00%
RPRX Royalty Pharma	+0.52%	+1.62%	+4.27%	+2.38%	+16.32%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CORT Corcept Therapeutics	4.821 of 5 stars	3.5	3.0	0.0	4.2	4.0	4.2	1.9
JAZZ Jazz Pharmaceuticals	4.838 of 5 stars	4.5	1.0	0.0	4.0	2.9	2.5	3.1
MDCO Medicines	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RPRX Royalty Pharma	4.3455 of 5 stars	3.5	1.0	2.5	3.7	2.9	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CORT Corcept Therapeutics	3.00	Buy	$143.25	99.29% Upside
JAZZ Jazz Pharmaceuticals	2.93	Moderate Buy	$187.71	60.49% Upside
MDCO Medicines	0.00	N/A	N/A	N/A
RPRX Royalty Pharma	3.00	Buy	$42.50	29.49% Upside

Current Analyst Ratings Breakdown

Latest MDCO, RPRX, CORT, and JAZZ Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/10/2025	JAZZ Jazz Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$210.00 ➝ $210.00
4/3/2025	CORT Corcept Therapeutics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$128.00 ➝ $131.00
4/1/2025	CORT Corcept Therapeutics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$130.00 ➝ $142.00
3/31/2025	CORT Corcept Therapeutics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$76.00 ➝ $150.00
3/31/2025	CORT Corcept Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$115.00 ➝ $150.00
3/28/2025	RPRX Royalty Pharma	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/10/2025	JAZZ Jazz Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$200.00 ➝ $217.00
3/7/2025	JAZZ Jazz Pharmaceuticals	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight	$175.00 ➝ $183.00
3/7/2025	JAZZ Jazz Pharmaceuticals	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$145.00 ➝ $179.00
3/6/2025	JAZZ Jazz Pharmaceuticals	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$220.00 ➝ $230.00
3/5/2025	JAZZ Jazz Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$210.00 ➝ $210.00

(Data available from 4/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CORT Corcept Therapeutics	$675.04M	11.23	$1.06 per share	67.96	$4.92 per share	14.61
JAZZ Jazz Pharmaceuticals	$4.07B	1.75	$23.82 per share	4.91	$59.36 per share	1.97
MDCO Medicines	$6.14M	1,102.36	N/A	N/A	($0.30) per share	-283.00
RPRX Royalty Pharma	$2.26B	8.36	$4.13 per share	7.94	$17.94 per share	1.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CORT Corcept Therapeutics	$106.14M	$1.24	57.05	38.85	N/A	22.35%	24.54%	20.24%	5/5/2025 (Estimated)
JAZZ Jazz Pharmaceuticals	$414.83M	$8.79	16.47	6.25	1.04	11.60%	29.30%	9.72%	5/6/2025 (Estimated)
MDCO Medicines	-$123.16M	-$2.91	N/A	N/A	N/A	N/A	N/A	-25.70%	N/A
RPRX Royalty Pharma	$858.98M	$1.45	22.63	6.75	2.31	37.94%	24.40%	14.01%	5/8/2025 (Estimated)

Latest MDCO, RPRX, CORT, and JAZZ Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	RPRX Royalty Pharma	$1.02	N/A	N/A	N/A	$724.69 million	N/A
5/6/2025	Q1 2025	JAZZ Jazz Pharmaceuticals	$4.65	N/A	N/A	N/A	$984.16 million	N/A
5/5/2025	Q1 2025	CORT Corcept Therapeutics	$0.17	N/A	N/A	N/A	$177.93 million	N/A
2/26/2025	Q4 2024	CORT Corcept Therapeutics	$0.37	$0.26	-$0.11	$0.26	$200.12 million	$181.89 million
2/11/2025	Q4 2024	RPRX Royalty Pharma	$0.99	$1.15	+$0.16	$0.35	$743.60 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CORT Corcept Therapeutics	N/A	N/A	N/A	N/A	N/A
JAZZ Jazz Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
MDCO Medicines	N/A	N/A	N/A	N/A	N/A
RPRX Royalty Pharma	$0.88	2.68%	+7.30%	60.69%	N/A

Latest MDCO, RPRX, CORT, and JAZZ Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/21/2025	RPRX Royalty Pharma	quarterly	$0.22	2.7%	5/16/2025	5/16/2025	6/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CORT Corcept Therapeutics	0.01	3.70	3.64
JAZZ Jazz Pharmaceuticals	1.46	4.26	3.74
MDCO Medicines	21.45	0.77	0.77
RPRX Royalty Pharma	0.64	1.44	1.44

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CORT Corcept Therapeutics	93.61%
JAZZ Jazz Pharmaceuticals	89.14%
MDCO Medicines	N/A
RPRX Royalty Pharma	54.35%

Insider Ownership

Company	Insider Ownership
CORT Corcept Therapeutics	20.50%
JAZZ Jazz Pharmaceuticals	4.20%
MDCO Medicines	8.41%
RPRX Royalty Pharma	18.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CORT Corcept Therapeutics	300	105.50 million	83.30 million	Optionable
JAZZ Jazz Pharmaceuticals	3,200	60.73 million	57.92 million	Optionable
MDCO Medicines	62	79.72 million	N/A	Optionable
RPRX Royalty Pharma	80	576.45 million	477.83 million	Optionable

MDCO, RPRX, CORT, and JAZZ Headlines

Recent News About These Companies

Tudor Investment Corp ET AL Has $18.75 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX)

April 30 at 7:05 AM | marketbeat.com

First Trust Advisors LP Sells 157,472 Shares of Royalty Pharma plc (NASDAQ:RPRX)

April 29 at 4:25 AM | marketbeat.com

Wells Fargo & Company MN Acquires 15,790 Shares of Royalty Pharma plc (NASDAQ:RPRX)

April 28 at 3:24 AM | marketbeat.com